BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 2467915)

  • 1. Biological functions of serine proteases in mast cells in allergic inflammation.
    Katunuma N; Kido H
    J Cell Biochem; 1988 Dec; 38(4):291-301. PubMed ID: 2467915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase.
    Goldstein SM; Leong J; Schwartz LB; Cooke D
    J Immunol; 1992 Apr; 148(8):2475-82. PubMed ID: 1560203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies and inhibitor of chymase are incorporated into mast cell granules and inhibit histamine release.
    Kido H; Fukusen N; Katunuma N
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():95-100. PubMed ID: 2462436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological functions of serine proteases in the granules of rat mast cells.
    Katunuma N; Fukusen N; Kido H
    Adv Enzyme Regul; 1986; 25():241-55. PubMed ID: 3544704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell chymase. A potent secretagogue for airway gland serous cells.
    Sommerhoff CP; Caughey GH; Finkbeiner WE; Lazarus SC; Basbaum CB; Nadel JA
    J Immunol; 1989 Apr; 142(7):2450-6. PubMed ID: 2494259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells.
    He S; Gaça MD; McEuen AR; Walls AF
    J Pharmacol Exp Ther; 1999 Nov; 291(2):517-23. PubMed ID: 10525066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells.
    Schwartz LB; Irani AM; Roller K; Castells MC; Schechter NM
    J Immunol; 1987 Apr; 138(8):2611-5. PubMed ID: 3549903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo.
    He S; Walls AF
    Br J Pharmacol; 1998 Dec; 125(7):1491-500. PubMed ID: 9884078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR
    Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase.
    Caughey GH; Leidig F; Viro NF; Nadel JA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):133-7. PubMed ID: 2447273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
    Huttunen M; Harvima IT
    Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts.
    Schechter NM; Brass LF; Lavker RM; Jensen PJ
    J Cell Physiol; 1998 Aug; 176(2):365-73. PubMed ID: 9648924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase.
    He S; Gaça MD; Walls AF
    J Pharmacol Exp Ther; 1998 Jul; 286(1):289-97. PubMed ID: 9655871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of histamine release from cultured human mast cells.
    Igarashi Y; Kurosawa M; Ishikawa O; Miyachi Y; Saito H; Ebisawa M; Iikura Y; Yanagida M; Uzumaki H; Nakahata T
    Clin Exp Allergy; 1996 May; 26(5):597-602. PubMed ID: 8735874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret.
    Franconi GM; Graf PD; Lazarus SC; Nadel JA; Caughey GH
    J Pharmacol Exp Ther; 1989 Mar; 248(3):947-51. PubMed ID: 2495355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chymotrypsin- and trypsin-type serine proteases in rat mast cells: properties and functions.
    Kido H; Fukusen N; Katunuma N
    Arch Biochem Biophys; 1985 Jun; 239(2):436-43. PubMed ID: 3890754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors.
    He S; Gaça MD; Walls AF
    Eur J Pharmacol; 2001 Feb; 412(3):223-9. PubMed ID: 11166285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.
    Kaminska R; Harvima IT; Naukkarinen A; Nilsson G; Horsmanheimo M
    J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
    Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
    Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release.
    He S; Aslam A; Gaça MD; He Y; Buckley MG; Hollenberg MD; Walls AF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):119-26. PubMed ID: 14722328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.